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Second cancer is a new cancer that occurs in someone who had history of cancer. The incidence of cancer 
is on the increase in the global scene and especially in Sub-Saharan Africa. This phenomenon constitutes 
huge health problems especially with comorbidity effects with other health conditions which have made the 
diagnosis and treatment of cancer patients a complex issue. Hence, this study determined the comorbidity 
effect on second cancer based on a retrospective study of 474 patients attending University of Abuja 
Teaching Hospital (UATH). These patients were first treated of cancer, and after one year developed 
another cancer or cancer free. The results revealed that the incidence of second cancer was approximately 
39.5% and 41.4% of the patients with one or more other disease(s) had second cancer. Adjusted and 
unadjusted odds ratio from logistic regression showed that patients with history of smoking were 3.58 times 
more likely to develop second cancer when no adjustment was made to the model while the risk increased 
after adjustment. Furthermore, cormobid patients are 1.56 times more likely to develop second cancer than 
cancer patients without other diseases. Based on the area under the receiver characteristics curve, logistic 
regression model effectively distinguished between the two groups of cancer patients. Comorbidity and 
smoking were identified as significant factors on the incidence of second cancer among cancer patients 
attending UATH. Therefore, emphasis should be given to formulating policies on controlling tobacco 
smoking and to create health awareness on the effect of clinical factors on second cancer within the study 
area. 
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INTRODUCTION 
Cancer is the name given to a group of conditions 
which causes cells to grow and divide 
uncontrollably thereby given rise to tumours, 
impairments and damage immune systems. It is a 
deadly disease and one of the most commonly 
diagnosed in recent times. The global rise in 
cancer is alarming particularly in developing 
countries where socio-economic conditions are 
poor and inhabitants’ live poverty line (World 
Bank, 2019). According to the WHO (2018) 
agency on cancer, the causes of cancer are 
hereditary factors and other three non-hereditary 
factors which are: physical carcinogen, chemical 
carcinogen and biological carcinogen, which has 
direct connection with lifestyle and genetic 
background. Some identifiable risk factors of 
cancer are use of tobacco, excessive alcohol 
intake, physical inactivity, unhealthy diet and 
some chronic infections. 
 
Cancer is one of the leading causes of death 
globally and is responsible for an estimated 8.2 
million deaths (WHO, 2018). There are about 
32.6 million reported cancer cases globally and 
14.1 million new cases documented in literature 
in 2012 (Salako et al., 2018). Global update in 
2018 revealed that there were about 18.1 million 
new cases with about 9.6 million deaths (WHO, 
2018). Following this trend, an estimated 16 
million new cases per annum are expected in 
2020 with over 70% of these cases expected 
from developing countries (Sowunmi et al., 2018). 
In Nigeria, the available records revealed that 
about 100,000 new cases of cancer occur every 
year with a high case fatality ratio. The aged 
standardized incidence rate of 58.3/100,000 men 
and 138.6/100,000 women were reported inthe 
Abuja cancer registry (Jedy-Agba et al., 2012; 
Sowunmi et al., 2018). This increased cancer 
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burden in recent times in Sub-Saharan Africa 
(SSA) and especially Nigeria constitutes health 
problems for the inhabitants and the government. 
These problems are enormous due to the 
comorbidity effects of other illnesses and 
conditions as over 70% of cancer cases have at 
least one comorbidity (Bellizzi and Rowland, 
2007). These comorbidities, however, have made 
treatment of cancer patients extremely difficult 
with negative impact on patients’ survival and 
quality of life. 
 
Comorbidities can be defined as medical 
illnesses unconnected in aetiology or causality to 
the major diagnosis that co-occur with the illness 
of interest (Bjorgul et al., 2010). It is the co-
occurrence of two or more disorders in the same 
individual at the same point in time with a primary 
condition.  It is imperative to recognise the 
comorbidities of the patient, because they may 
interrupt diagnosis, change treatment, lead to 
complications, influence survival, and confound 
analysis of outcomes (Bjorgul et al., 2010). 
Cancer patients are likely to be comorbid which 
could complicate treatment and broaden 
management (Pule et al., 2019). Patient 
comorbidity has a significant influence on cancer 
stage at diagnosis; however, this influence varies 
significantly by cancer type (Gurney et al., 2015). 
Severe comorbidity may affect life expectancy 
and limiting diagnostic investigation (Salako et 
al., 2018). Studies have identified cardiovascular 
disease, hypertension, asthma and diabetes to 
behighly prevalent with cancer of the breast, 
cervical, prostate and colorectal cancer in Nigeria 
(Giovannucci et al., 2010; Maiyaki and Garbati, 
2014). 
 
Second cancer is a new cancer that occurs in 
someone who had history of cancer. It is often a 
new type of cancer different from the first.Causes 
of second cancer is not always clear; it may result 
from the same causative agent as the first while 
others may be caused by cancer treatments 
(American Cancer Society, (ACS), 2019) though 
the risk of developinga second cancer due to 
chemotherapy of the first cancer is rare. 
According to national comprehension cancer 
network (NCCN), there are set of patients that 
may likely stand the risk of second unrelated 
cancer due to some health related factors, which 
include patients who have cancer before 15 years 
(childhood cancer), immunodeficiency and 
medicine, aging and hormonal related issues 
(NCCN, 2020). Other identifiable risk factors 
could be genetic, left-over of cancer after 
treatment, smoking, use of alcohol, unhealthy 
diet, chronic infection, physical inactivity amongst 
others (Abdelrahman, 2010; Sharp et al., 2014).  
 
Studies on the impact of comorbidities on second 
cancer occurrence in Nigeria are scarce and such 
information can influence diagnosis, prognosis, 
treatment outcomes and survival probability of 
first cancer occurrence. It is imperative therefore, 
to assess the effect of comorbidities on second 
cancer occurrence to address paucity of 
information on the effect of comorbidity on 
second cancer in Nigeria. Therefore, this study 
explores the comorbidity effect on second cancer 
using a binary logistic regression model (LRM). 
 
MATERIALS AND METHODS 
Data Collection 
Data of 474 patients were obtained for this study 
from hospital based cancer register of patients 
attending University of Abuja Teaching Hospital 
(UATH), Abuja Nigeria, for primary diagnosis and 
treatment. Relevant data were collected as 
secondary data from cancer registry of UATH. 
Data collected include demographic data such as 
information on age at diagnosis, sex, marital 
status, smoking history, educational background, 
area of residence and clinical status which is 
comorbidity. 
 
Description and Coding of Variables 
Table 1 presents the coding of variables that 
were used for this study. 
 
Data presentation  
Descriptive statistics such as mean and standard 
deviation were adopted to describe continuous 
variable while frequency and percentage were 
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done to describe categorical variables. Also, 
cross-tabulation was performed to ascertain 
association between the second cancer 
occurrence and explanatory variables.  
 
Logistic Regression Model 
Logistic regression model is a statistical tool for 
modelling a binary dependent variable with one 
or more independent variables. It is a generalized 
linear regression model which uses logit as link 
function for the transformation of the model 
components. This study adopted LRM due to the 
fact that the response variable is dichotomous 
and LRM easily handles continuous covariates 
without discretization (Oguntade, 2018). Similarly, 
LRM was explored to examine the association 
between second cancer occurrence and socio-
demographic characteristics, lifestyle and 
comorbidity status of cancer patients attending 
UATH. 
 
Let P(xi) represents the probability of an event for 
the subject  i , ix are the vectors of random 
variables and the response variable denoted by 
y  assumes values zero when there is non-
occurrence and one when there is second cancer 





Logit (P) = log [P(x)/1-P(x)] = β0 + β1 Xage + β2Xgender + β3Xcomorbidity+ β4Xsmoking + β5Xmarital status + β6XArea 
β7XEducational B/G 
p=
                                                                                           
                                                                                          
 
 
Table 1: Description of explanatory variables, codes and citations from related studies 
Variables Codes Description Sources 
Age at first 
diagnosis 
Quantitative Older age increases the chances 
of second cancer 
Immunosenescene sets in with 
advanced in age 
Castelo-Brancoand 
Soveral (2014); Salako 
et al. (2018) 
 
Gender 1 Male 
0 Female 
Male increases the chance of 
cancer 
Kim et al. (2018);Tevfik 
et al. (2012) 
 
Comorbidity 1 Present 
0 Absent 
Presence of secondary condition 
increases the likelihood of second 
cancer 
Salako et al. (2018) 
 
 
Marital status 1 Married 
0 Single 
Married subjects has a decreased 
tendency of second cancer 
Swanson et al. (1985); 






Living in urban area has an 
increased probability of second 
cancer 
Sharp et al.(2014); 
Meilleur et al. (2013) 
 
Education 1 Educated 
0 Illiterate 
Literacy decreases the chance of 
cancer 
Mouw et al (2008); 
Leuven et al. (2016) 
 
Crude odd ratio method was used to ascertain 
individual strength of association using simple 
LRM while the partial adjusted or multiple LRM 
was performed to determine the true strength of 
association among the studied covariates. The 
classification accuracy was examined with the 
Receiver Operating characteristic (ROC). This 
showed the trade-off between the correct 
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classification of those that have second cancer 
(true positive rate) and incorrect classification of 
those that have second cancer (false positive 
rate). This was done with the plot of the 
probability of detecting true patients with second 
cancer (sensitivity) and false patients with second 
cancer (1-specificity) for the entire range of 
possible cut off points. The area under the curve 
revealed the average sensitivity over possible 
specificities for evaluation of the performance of 
the classifier. The closer the value of the area 
under the curve to 100%, the larger the sensitivity 
and also the specificity values, and hence, the 




The data for this study were exclusively 
information about anonymous human subjects 
from UATH. Approval was obtained from UATH 
prior to the commencement of this study. 
 
RESULTS 
It was observed that out of 474 patients, 
191(40.3%) were male while 283 (59.7%) were 
females.The distribution of the result by area of 
residence showed that 151(31.9%) were rural 
dwellers while 323(68.1%) live in urban area. 
17.3% were single and 82.7% were married, 
33.1% of the patients have history of smoking 
while 66.9% were never smoked. The result by 
education background showed that 41.4% were 
never been to school and cannot read and write 
while 58.6% were educated (had at least primary 
education). In term of comorbidity status, 196 
(41.4%) have other disease(s) apart from cancer 
and 278 (58.6%) do have only cancer. The 
second cancer status showed that 39.5% have 
second cancer while the remaining 60.5% do not 
have second cancer (Table 2). 
 
Table 2: Demographic characteristics and 
medical history of cancer patients attending 
UATH 
Variables Frequency % 
Gender   
Male 191 40.3 
Female 283 59.7 
Residential Area   
Rural 151 31.9 
Urban 323 68.1 
Marital Status   
Single 82 17.3 
Married 392 82.7 
Smoking Status   
Yes 157 33.1 
No 317 66.9 
Education    
Not Educated 196 41.4 




Yes 196 41.4 
No 278 58.6 
Second Cancer Status  
Yes 187 39.5 
No 286 60.5 
 
Table 3 shows that male patients that have 
second cancer is 51.1%, while 31.8% of all the 
females had second cancer, 40% of rural 
dwellers had second cancer, 39.3% those that 
live in urban had second cancer, 40.2% of single 
had second cancer, 39.4% of those that married 
had second cancer, 41.5% of illiterate patients 
had second cancer, 36.7% of educated patients 
had second cancer, 44.4% of patients that had 
one or more other disease(s) had second cancer 
while 36.1% of patients that had only cancer had 
second cancer. 
 
Table 3: Cross-tabulation of studiedcovariates 
and second cancer occurrence among cancer 
patients attending UATH 
Variable Second Cancer Status 
Gender Yes (%) No (%) 
Male 97(51.1) 93(48.9) 
Female 90(31.8) 193(68.2) 
Area of   
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Residence 
Rural 60(40) 90(60) 
Urban 127(39.3) 196(60.7) 
Marital status   
Single 33(40.2) 49(59.8) 
Married 154(39.4) 237(60.6) 
Smoking   
Yes 94(59.9) 63(40.1) 




Illiterate 115(41.5) 162(58.5) 
Educated 72(36.7) 124(63.3) 
Comorbidity   
Yes 87(44.4) 109(55.6) 
No 100(36.1) 177(63.9) 
Values in parenthesis are expressed in percentages 
 
The cross product ratios (Table 5) revealed that 
male patients were 2.23 times more likely to 
develop second cancer; patients with history of 
smoking were 3.58 times more likely to develop 
second cancer when no adjustment was made to 
the model or without any control variable(s). Risk 
of second cancer reduced among male patients 
after adjustment for other variables, the risk of 
second cancer was 4.13 times more likely among 
the patients with history of smoking. Also, 
patients who were diagnosed of other disease(s) 
were 1.56 times more likely to develop second 
cancer than cancer patients without another 
disease(s). Marriage reduced the risk of second 
cancer by 44%. Living in urban area reduced the 
likelihood of developing second cancer by 11%. 
The odds for educated to illiterates to develop 
second cancer are 1.36 (Tables 4, 5). 
 
Table 4: Logistic regression model parameter estimate and its related statistics 
Covariates Coef. Std.err z p>|z| (95% CI) 
Gender -0.90 0.21 -4.27 0.001 (-1.31   -0.49) 
Age -0.02 0.01 -3.19 0.001 (-0.04     -0.09) 
Area of 
Residence 
-0.19 0.22 -0.89 0.374 (-0.620.23) 
Marital Status -0.62 0.31 -1.99 0.046 (-1.23   -0.01) 
Smoking 1.35 0.21 6.37 0.001 (0.93      1.76) 
Education 0.35 0.21 1.62 0.106 (-0.07   0 .76) 
Comorbid 0.20 0.20 2.04 0.041 (0.020.82) 
Coef.: Coefficient; Std err: Standard error; z: z-score; p>|z|: P-value; CI: Confidence interval 
 
Table 5: Cross product ratioof studied covariates and second cancer occurrence with their associated 
estimatesamong cancer patients attending UATH. 
Variable Unadjusted Odds 
ratio 
[95% CI] Odds 
Ratio 
[95% CI] 
Gender 2.23 (1.5  3.33) 0.41 (0.27 .62) 
Area of 
Residence 
1.03 (0.69 1.56) 0.89 (0.58 1.40) 
Marital status 1.04 (0.62 1.73) 0.56 (0.30  1.03) 
Smoking status 3.58 (2.35 5.45) 4.13 (2.70 6.33) 
Education 1.22 (0.83 1.81) 1.36 (0.88  2.08) 
Comorbidity 1.41 (0.96 2.08) 1.56 (1.03  2.34) 
CI: Confidence Interval 
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Assessment of logistic regression model of 
second cancer occurrence 
The likelihood ratio test at 0.05 level of 
significance was highly significant (G = 58.1, 
p<0.001), which implies that at least one of the 
coefficients of the model is different from zero. 
Table 6 displays the goodness-of-fit statistic 
which indicated that the model was well fitted. 
 
Table 6: Performance of a classification test of 
logistic regression model of second cancer 
occurrence  
Test  Statistics Value 
Number of Observations 474 
Number of Covariate patterns 327 
Pearson Chi2 339.06 
Prob chi2 0.222 
Correctly classified 67 
True D definition as second cancer 0 
Sensitivity Pr(+D) 48.7% 
Specificity Pr(-D) 80.8% 
Positive predictive value Pr(D+) 62.3% 
Negative predictive value Pr(D-) 70.6% 
False+rate for true~DPr( +|~D) 19.2% 
False-rate for true D  Pr( -| D) 51.3% 
False+rate for classified+ Pr(~D| +) 37.7% 
False-rate for classified- Pr( D| -) 29.4% 
Correctly classified 68.1% 
 
 
Figure 1: Receiver Operating Characteristics 
(ROC) curve derived from logistic regression 
model of second cancer occurrence 
 
DISCUSSION 
This study applied LRM to identify associated risk 
factors of developing second cancer. The risk 
factors examined span socio-demographics and 
clinical risks factors of patients visiting UATH for 
treatment. These factors include gender, age at 
first cancer, patient residence, marital status, 
education status, lifestyle which is history of 
smoking and the clinical risk factor (comorbidity).  
 
Based on the result of this study, gender, 
smoking and comorbidity were identified as 
significant risk factors for second cancer 
occurrence. This result is in line with a related 
study in Lagos, Nigeria (Salako et al., 2018). 
Similarly, this study revealed that the odds ratio 
of present to absent of other disease(s) ranges 
between 1.03 times to 2.34 times with 95% 
confidence level. This result is consistent with 
earlier assertion that comorbidity may affect life 
expectancy and limiting diagnostic investigation 
(Giovannucci et al., 2010). Furthermore, some 
comorbid conditions may have a direct effect on 
cancer growth which invariably may lead to 
second cancer occurrence. Comorbidity has 
direct influence on prognosis, treatment outcome 
and survival probabilities of the patient(s) (Salako 
et al., 2018). The results of this present study 
also revealed that age at first cancer was 
indirectly related to second cancer occurrence. 
This implies that the earlier a patient developed 
the first cancer in life, the higher the chance of 
having a second cancer and vice versa. This is 
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consistent with the assertion documented in 
related literature on incidence of second cancer 
(Abdelrahman, 2010; ACS, 2019).The authors 
found that the age of an individual subject at the 
time of first treatment of cancer has a significant 
effect on the development of other cancer in the 
later years.  
 
The area under ROC (Figure 1) indicates that 
logistic regression has an ability to distinguish 
between the two groups which support a similar 
finding in literature (Abdelrahman, 2010). The 
author noted that logistic regression has low 
sensitivity because of absent of clinical risk factor 
which was not considered. 
 
CONCLUSION 
Based on the results of the analyses carried out 
on the second cancer occurrence, comorbidity 
and smoking were found to increase the chance 
of second cancer occurrence within the study 
area and its environs. Logistic regression model 
has reasonable sensitivity to distinguish between 
‘second cancer’ and ‘no second cancer’ groups. 
Therefore, emphasis should be given to 
formulating policies on controlling tobacco 
smoking and to create health awareness on the 
effect of clinical factors on second cancer 
occurrence to curb the menace of cancer within 
the study area and its environs.  
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